Published in Am J Respir Crit Care Med on August 15, 2001
Efficacy and Safety of Sirolimus for Treating Lymphangioleiomyomatosis (LAM) | NCT00414648
Safety and Efficacy of Saracatinib In Subjects With Lymphangioleiomyomatosis (SLAM-2) | NCT02737202
Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis. N Engl J Med (2008) 9.64
The NHLBI lymphangioleiomyomatosis registry: characteristics of 230 patients at enrollment. Am J Respir Crit Care Med (2005) 4.15
Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 Iinternational Tuberous Sclerosis Complex Consensus Conference. Pediatr Neurol (2013) 3.49
Changes in lung function and chylous effusions in patients with lymphangioleiomyomatosis treated with sirolimus. Ann Intern Med (2011) 2.67
Molecular and genetic analysis of disseminated neoplastic cells in lymphangioleiomyomatosis. Proc Natl Acad Sci U S A (2004) 2.27
Recognition of tuberous sclerosis in adult women: delayed presentation with life-threatening consequences. Ann Intern Med (2011) 1.92
Lymphangioleiomyomatosis - a wolf in sheep's clothing. J Clin Invest (2012) 1.87
Estrogen promotes the survival and pulmonary metastasis of tuberin-null cells. Proc Natl Acad Sci U S A (2009) 1.75
Lymphangioleiomyomatosis: what do we know and what are we looking for? Eur Respir Rev (2011) 1.73
Serum vascular endothelial growth factor-D prospectively distinguishes lymphangioleiomyomatosis from other diseases. Chest (2010) 1.52
Multicenter phase 2 trial of sirolimus for tuberous sclerosis: kidney angiomyolipomas and other tumors regress and VEGF- D levels decrease. PLoS One (2011) 1.48
Molecular pathogenesis of lymphangioleiomyomatosis: lessons learned from orphans. Am J Respir Cell Mol Biol (2006) 1.47
Dyspnea in a 43-year-old woman with polycystic kidney disease. Chest (2009) 1.38
Serum vascular endothelial growth factor-D levels in patients with lymphangioleiomyomatosis reflect lymphatic involvement. Chest (2009) 1.28
Tuberous sclerosis complex: neurological, renal and pulmonary manifestations. Neuropediatrics (2011) 1.27
The natural history of lymphangioleiomyomatosis: markers of severity, rate of progression and prognosis. Lymphat Res Biol (2010) 1.27
Abnormal growth of smooth muscle-like cells in lymphangioleiomyomatosis: Role for tumor suppressor TSC2. Am J Respir Cell Mol Biol (2006) 1.24
Utility of [18F]2-fluoro-2-deoxyglucose-PET in sporadic and tuberous sclerosis-associated lymphangioleiomyomatosis. Chest (2009) 1.19
Topical rapamycin inhibits tuberous sclerosis tumor growth in a nude mouse model. BMC Dermatol (2008) 1.12
mTOR activation, lymphangiogenesis, and estrogen-mediated cell survival: the "perfect storm" of pro-metastatic factors in LAM pathogenesis. Lymphat Res Biol (2010) 1.05
Mammalian target of rapamycin signaling and autophagy: roles in lymphangioleiomyomatosis therapy. Proc Am Thorac Soc (2010) 0.99
Sudden onset of dyspnea in a woman with skin lesions and lung cysts. Lung India (2013) 0.96
Clinical features, epidemiology, and therapy of lymphangioleiomyomatosis. Clin Epidemiol (2015) 0.95
Lymphangioleiomyomatosis: differential diagnosis and optimal management. Ther Clin Risk Manag (2014) 0.93
Association between a high-expressing interferon-gamma allele and a lower frequency of kidney angiomyolipomas in TSC2 patients. Am J Hum Genet (2002) 0.93
Lymphangioleiomyomatosis. MedGenMed (2006) 0.93
Lymphangioleiomyomatosis (LAM): molecular insights lead to targeted therapies. Respir Med (2010) 0.92
Frequency of undiagnosed cystic lung disease in patients with sporadic renal angiomyolipomas. Chest (2011) 0.92
Interferon-gamma-Jak-Stat signaling in pulmonary lymphangioleiomyomatosis and renal angiomyolipoma: a potential therapeutic target. Am J Respir Cell Mol Biol (2005) 0.92
Massive bilateral renal angiomyolipomatosis and multifocal micronodular pneumocytes hyperplasia associated with tuberous sclerosis: a case report. Wien Klin Wochenschr (2011) 0.91
Lymphatics in lymphangioleiomyomatosis and idiopathic pulmonary fibrosis. Eur Respir Rev (2012) 0.90
Effusion cytology: an effective method for the diagnosis of pulmonary lymphangioleiomyomatosis. J Thorac Dis (2014) 0.89
Distinct clinical characteristics of tuberous sclerosis complex patients with no mutation identified. Ann Hum Genet (2008) 0.89
Tuberous sclerosis complex: the past and the future. Pediatr Nephrol (2014) 0.86
Tuberous Sclerosis Complex: State-of-the-Art Review with a Focus on Pulmonary Involvement. Lung (2015) 0.86
Lymphatic involvement in lymphangioleiomyomatosis. Ann N Y Acad Sci (2008) 0.85
Involvement of lymphatics in lymphangioleiomyomatosis. Lymphat Res Biol (2009) 0.85
Reversible airflow obstruction in lymphangioleiomyomatosis. Chest (2009) 0.84
Lymphangioleiomyomatosis: a case-control study of perinatal and early life events. Thorax (2003) 0.82
Women with TSC: Relationship between Clinical, Lung Function and Radiological Features in a Genotyped Population Investigated for Lymphangioleiomyomatosis. PLoS One (2016) 0.82
Similar trends in serum VEGF-D levels and kidney angiomyolipoma responses with longer duration sirolimus treatment in adults with tuberous sclerosis. PLoS One (2013) 0.81
Pharmacokinetics and pharmacodynamics of everolimus in patients with renal angiomyolipoma and tuberous sclerosis complex or lymphangioleiomyomatosis. Br J Clin Pharmacol (2016) 0.80
Reversed halo sign in tuberous sclerosis complex. Case Rep Radiol (2013) 0.80
Rare lung diseases I--Lymphangioleiomyomatosis. Can Respir J (2006) 0.80
SRC kinase is a novel therapeutic target in lymphangioleiomyomatosis. Cancer Res (2014) 0.79
Lymphatic endothelial differentiation in pulmonary lymphangioleiomyomatosis cells. J Histochem Cytochem (2013) 0.79
Lymphangioleiomyomatosis: New Treatment Perspectives. Lung (2015) 0.78
Prevalence of uterine leiomyomas in lymphangioleiomyomatosis. Fertil Steril (2011) 0.76
Treatment of renal angiomyolipoma in tuberous sclerosis complex (TSC) patients. Pediatr Nephrol (2016) 0.76
Tuberous sclerosis complex: imaging the pieces of the puzzle. Radiol Bras (2017) 0.75
Multifocal pneumocyte hyperplasia in tuberous sclerosis. BMJ Case Rep (2009) 0.75
Multifocal micronodular pneumocyte hyperplasia (MMPH) in a patient with tuberous sclerosis-evidence for long term stability. Respir Med Case Rep (2017) 0.75
mTOR inhibitors in the pharmacologic management of tuberous sclerosis complex and their potential role in other rare neurodevelopmental disorders. Orphanet J Rare Dis (2017) 0.75
New developments in the genetics and pathogenesis of tumours in tuberous sclerosis complex. J Pathol (2016) 0.75
Lymphangioleiomyomatosis. Atlas Genet Cytogenet Oncol Haematol (2015) 0.75
Proapoptotic protein Bim attenuates estrogen-enhanced survival in lymphangioleiomyomatosis. JCI Insight (2016) 0.75
Tuberous sclerosis diagnosed by incidental computed tomography findings of multifocal micronodular pneumocyte hyperplasia: a case report. J Med Case Rep (2012) 0.75
Imaging of tuberous sclerosis complex: a pictorial review. Radiol Bras (2017) 0.75
The new World Health Organization classification of lung tumours. Eur Respir J (2001) 6.91
Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34. Science (1997) 6.10
A comparison of amphotericin B alone and combined with flucytosine in the treatment of cryptoccal meningitis. N Engl J Med (1979) 5.87
Nonmuscle actin-binding proteins. Annu Rev Cell Biol (1985) 5.46
Actin-binding protein requirement for cortical stability and efficient locomotion. Science (1992) 4.66
Transforming growth factor beta 1 is present at sites of extracellular matrix gene expression in human pulmonary fibrosis. Proc Natl Acad Sci U S A (1991) 4.61
Randomised placebo-controlled trial of ritonavir in advanced HIV-1 disease. The Advanced HIV Disease Ritonavir Study Group. Lancet (1998) 4.54
Idiopathic pulmonary fibrosis: relationship between histopathologic features and mortality. Am J Respir Crit Care Med (2001) 4.45
Expression of murine STF-1, a putative insulin gene transcription factor, in beta cells of pancreas, duodenal epithelium and pancreatic exocrine and endocrine progenitors during ontogeny. Development (1995) 4.38
Caspase-3-generated fragment of gelsolin: effector of morphological change in apoptosis. Science (1997) 4.19
Long-term survival after resection for ductal adenocarcinoma of the pancreas. Is it really improving? Ann Surg (1995) 4.17
Histopathologic variability in usual and nonspecific interstitial pneumonias. Am J Respir Crit Care Med (2001) 4.01
Pulmonary Langerhans'-cell histiocytosis. N Engl J Med (2000) 3.83
Bronchiolitis obliterans organizing pneumonia. N Engl J Med (1985) 3.78
Human endothelial actin-binding protein (ABP-280, nonmuscle filamin): a molecular leaf spring. J Cell Biol (1990) 3.76
Mechanisms that control knox gene expression in the Arabidopsis shoot. Development (2000) 3.62
Plasma and cytoplasmic gelsolins are encoded by a single gene and contain a duplicated actin-binding domain. Nature (1986) 3.50
Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2, compared with TSC1, disease in multiple organs. Am J Hum Genet (2000) 3.44
Tsc2(+/-) mice develop tumors in multiple sites that express gelsolin and are influenced by genetic background. J Clin Invest (1999) 3.38
Hemostatic, inflammatory, and fibroblast responses are blunted in mice lacking gelsolin. Cell (1995) 3.08
Actin-binding proteins. Curr Opin Cell Biol (1991) 2.83
Sudden-onset fatal asthma. A distinct entity with few eosinophils and relatively more neutrophils in the airway submucosa? Am Rev Respir Dis (1993) 2.83
Lymphangioleiomyomatosis. Clinical course in 32 patients. N Engl J Med (1990) 2.76
Molecular genetic advances in tuberous sclerosis. Hum Genet (2000) 2.72
Pivotal study of iodine I 131 tositumomab for chemotherapy-refractory low-grade or transformed low-grade B-cell non-Hodgkin's lymphomas. J Clin Oncol (2001) 2.71
Allelic loss is frequent in tuberous sclerosis kidney lesions but rare in brain lesions. Am J Hum Genet (1996) 2.67
The prognostic significance of the histologic pattern of interstitial pneumonia in patients presenting with the clinical entity of cryptogenic fibrosing alveolitis. Am J Respir Crit Care Med (2000) 2.63
Radiological versus histological diagnosis in UIP and NSIP: survival implications. Thorax (2003) 2.54
Amplification of EGFR T790M causes resistance to an irreversible EGFR inhibitor. Oncogene (2010) 2.53
Cigarette smoking: a risk factor for idiopathic pulmonary fibrosis. Am J Respir Crit Care Med (1997) 2.42
Screening for mental health: validity of the MHI-5 using DSM-IV Axis I psychiatric disorders as gold standard. Psychiatry Res (2001) 2.42
Follicular bronchitis/bronchiolitis. Hum Pathol (1985) 2.40
Thoracic lymphangiomas, lymphangiectasis, lymphangiomatosis, and lymphatic dysplasia syndrome. Am J Respir Crit Care Med (2000) 2.30
Characterization of motifs which are critical for activity of the cyclic AMP-responsive transcription factor CREB. Mol Cell Biol (1991) 2.27
Redesign of PCR primers for mitochondrial cytochrome c oxidase subunit I for marine invertebrates and application in all-taxa biotic surveys. Mol Ecol Resour (2013) 2.27
Enhanced motility in NIH 3T3 fibroblasts that overexpress gelsolin. Science (1991) 2.26
Gelsolin is a downstream effector of rac for fibroblast motility. EMBO J (1998) 2.23
Idiopathic nonspecific interstitial pneumonia/fibrosis: comparison with idiopathic pulmonary fibrosis and BOOP. Eur Respir J (1998) 2.23
Factors influencing remission from alcohol dependence without formal help in a representative population sample. Addiction (2001) 2.22
Nonspecific interstitial pneumonia and usual interstitial pneumonia: comparative appearances at and diagnostic accuracy of thin-section CT. Radiology (2001) 2.20
Loss of heterozygosity in the tuberous sclerosis (TSC2) region of chromosome band 16p13 occurs in sporadic as well as TSC-associated renal angiomyolipomas. Genes Chromosomes Cancer (1995) 2.20
Cdc42 is required for PIP(2)-induced actin polymerization and early development but not for cell viability. Curr Biol (2000) 2.19
Clinical significance of histological classification of idiopathic interstitial pneumonia. Eur Respir J (2002) 2.19
Cutaneous adverse drug reactions: clinical pattern and causative agents--a 6 year series from Chandigarh, India. J Postgrad Med (2002) 2.15
Resistance-related mutations in the HIV-1 protease gene of patients treated for 1 year with the protease inhibitor ritonavir (ABT-538). AIDS (1996) 2.14
Evidence that lymphangiomyomatosis is caused by TSC2 mutations: chromosome 16p13 loss of heterozygosity in angiomyolipomas and lymph nodes from women with lymphangiomyomatosis. Am J Hum Genet (1998) 2.13
A histologic pattern of nonspecific interstitial pneumonia is associated with a better prognosis than usual interstitial pneumonia in patients with cryptogenic fibrosing alveolitis. Am J Respir Crit Care Med (1999) 2.08
Lymphatic manifestations of lymphangioleiomyomatosis. Lymphology (2014) 2.06
Volumetric spectroscopic imaging with spiral-based k-space trajectories. Magn Reson Med (1998) 2.05
Cloning of DNA fragments complementary to tobacco nitrate reductase mRNA and encoding epitopes common to the nitrate reductases from higher plants. Mol Gen Genet (1987) 2.05
Validation of an instrument to measure voice-related quality of life (V-RQOL). J Voice (1999) 2.04
Idiopathic pulmonary fibrosis: current concepts. Mayo Clin Proc (1998) 2.04
Renal gluconeogenesis: its importance in human glucose homeostasis. Diabetes Care (2001) 2.02
CDX-2 homeobox gene expression is a reliable marker of colorectal adenocarcinoma metastases to the lungs. Am J Surg Pathol (2003) 2.01
Association of common CRP gene variants with CRP levels and cardiovascular events. Ann Hum Genet (2005) 2.00
The lung in inflammatory bowel disease. Medicine (Baltimore) (1993) 1.98
Methotrexate pneumonitis: review of the literature and histopathological findings in nine patients. Eur Respir J (2000) 1.97
The spectrum of serous cystadenoma of the pancreas. Clinical, pathologic, and surgical aspects. Ann Surg (1992) 1.96
Clear cell tumor of the lung. A clinicopathologic, immunohistochemical, and ultrastructural study of eight cases. Am J Surg Pathol (1990) 1.92
Hamman-Rich syndrome revisited. Mayo Clin Proc (1990) 1.92
The surgical management of nontraumatic ectopic lenses. J Pediatr Ophthalmol Strabismus (1996) 1.91
Linear IgA disease of adults: association with lymphoproliferative malignancy and possible role of other triggering factors. Br J Dermatol (1990) 1.91
Human serum alpha 1 acid glycoprotein reduces uptake, intracellular concentration, and antiviral activity of A-80987, an inhibitor of the human immunodeficiency virus type 1 protease. Antimicrob Agents Chemother (1996) 1.89
Dystonia gene in Ashkenazi Jewish population is located on chromosome 9q32-34. Ann Neurol (1990) 1.89
Insulin expression in pancreatic islet cells relies on cooperative interactions between the helix loop helix factor E47 and the homeobox factor STF-1. Mol Endocrinol (1994) 1.89
Structure and biosynthesis of cytoplasmic and secreted variants of gelsolin. J Biol Chem (1984) 1.87
The lung in inflammatory bowel disease. Eur Respir J (2000) 1.87
Comprehensive management of children on a paediatric ward: a family approach. Arch Dis Child (1980) 1.86
Lung nodule enhancement at CT: prospective findings. Radiology (1996) 1.85
Coordinated regulation of platelet actin filament barbed ends by gelsolin and capping protein. J Cell Biol (1996) 1.85
Expression of the potato tuber ADP-glucose pyrophosphorylase in Escherichia coli. J Biol Chem (1993) 1.83
BAL findings in idiopathic nonspecific interstitial pneumonia and usual interstitial pneumonia. Eur Respir J (2003) 1.81
An integration-defective U5 deletion mutant of human immunodeficiency virus type 1 reverts by eliminating additional long terminal repeat sequences. J Virol (1994) 1.81
Pulmonary nodules: CT evaluation of enhancement with iodinated contrast material. Radiology (1995) 1.78
Lymphoepithelioma-like carcinoma of the lung. Am J Surg Pathol (1989) 1.77
Immunofluorescent staining for mast cells in idiopathic pulmonary fibrosis: quantification and evidence for extracellular release of mast cell tryptase. Mayo Clin Proc (1992) 1.77
Ultrafast computed tomography as a diagnostic modality in the detection of coronary artery disease: a multicenter study. Circulation (1996) 1.76
Pulmonary surfactant protein A mediates enhanced phagocytosis of Mycobacterium tuberculosis by a direct interaction with human macrophages. J Immunol (1995) 1.74
Connective tissue growth factor mRNA expression is upregulated in bleomycin-induced lung fibrosis. Am J Physiol (1998) 1.73
Oncogenic Ras inhibits Fas ligand-mediated apoptosis by downregulating the expression of Fas. EMBO J (1999) 1.73
Primary focal dystonia: evidence for distinct neuropsychiatric and personality profiles. J Neurol Neurosurg Psychiatry (2009) 1.70
Suppression of tumorigenicity in simian virus 40-transformed 3T3 cells transfected with alpha-actinin cDNA. Proc Natl Acad Sci U S A (1993) 1.69
Profilin I is essential for cell survival and cell division in early mouse development. Proc Natl Acad Sci U S A (2001) 1.68
EGF receptor regulation of cell motility: EGF induces disassembly of focal adhesions independently of the motility-associated PLCgamma signaling pathway. J Cell Sci (1998) 1.68
Transverse-momentum and pseudorapidity distributions of charged hadrons in pp collisions at square root of s = 7 TeV. Phys Rev Lett (2010) 1.67
Nitrate, a signal relieving seed dormancy in Arabidopsis. Plant Cell Environ (2005) 1.66
Clinical course and lung function change of idiopathic nonspecific interstitial pneumonia. Eur Respir J (2008) 1.65
Studies on natural recovery from alcohol dependence: sample selection bias by media solicitation? Addiction (2000) 1.65
Pulmonary and mediastinal glomus tumors--report of five cases including a pulmonary glomangiosarcoma: a clinicopathologic study with literature review. Am J Surg Pathol (2000) 1.64
Early embryonic death of mice deficient in gamma-adaptin. J Biol Chem (1999) 1.64
Loss of tuberin in both subependymal giant cell astrocytomas and angiomyolipomas supports a two-hit model for the pathogenesis of tuberous sclerosis tumors. Am J Pathol (1997) 1.63
Neurologic manifestations of Churg-Strauss syndrome. Mayo Clin Proc (1995) 1.61
Analysis of lymphoepithelioma and lymphoepithelioma-like carcinomas for Epstein-Barr viral genomes by in situ hybridization. Am J Surg Pathol (1989) 1.60
Search for supersymmetry using final states with one lepton, jets, and missing transverse momentum with the ATLAS detector in √s=7 TeV pp collisions. Phys Rev Lett (2011) 1.60
Bronchioloalveolar carcinoma of the lung: recurrences and survival in patients with stage I disease. J Thorac Cardiovasc Surg (2001) 1.60
The separation of benign and malignant mesothelial proliferations. Am J Surg Pathol (2000) 1.59
Carcinoma of the body and tail of the pancreas: is curative resection justified? Surgery (1992) 1.59
Tissue eosinophilia and eosinophil degranulation in syndromes associated with fibrosis. Am J Pathol (1992) 1.58
Mesothelial/monocytic incidental cardiac excrescences: cardiac MICE. Mod Pathol (1994) 1.58
Parthenium dermatitis treated with azathioprine weekly pulse doses. Indian J Dermatol Venereol Leprol (2006) 1.57